Literature DB >> 19163190

Tissue-specific RMA models to incrementally normalize Affymetrix GeneChip data.

Steven A Eschrich1, Andrew M Hoerter, Gregory C Bloom, David A Fenstermacher.   

Abstract

Gene expression classifiers have been used to predict diagnosis of disease, patient prognosis and patient response to therapy. Although there have been remarkable successes in this area, a particular goal of personalized medicine is the ability predict a response from a single gene expression microarray. One aspect of this problem is the normalization of microarrays. Affymetrix GeneChip microarrays are typically processed using model-based algorithms that require all of the data in order to adequately estimate the model. We experiment with the RMA normalization procedure in an incremental fashion, adding new chips to an existing normalization model. Focusing on tissue-specific normalization models, we generate datasets that have very small differences from a batch normalization. Through several large datasets of patient samples, we provide evidence that RMA models of normalization converge to a common model in homogenous samples. These results offer the promise of maintaining large data warehouses of patient microarray samples without the requirement of constant renormalization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19163190     DOI: 10.1109/IEMBS.2008.4649687

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  3 in total

1.  Hybrid model integrating immunohistochemistry and expression profiling for the classification of carcinomas of unknown primary site.

Authors:  Barbara A Centeno; Gregory Bloom; Dung-Tsa Chen; Zhihua Chen; Mike Gruidl; Aejaz Nasir; Timothy Y Yeatman
Journal:  J Mol Diagn       Date:  2010-06-17       Impact factor: 5.568

2.  Iterative rank-order normalization of gene expression microarray data.

Authors:  Eric A Welsh; Steven A Eschrich; Anders E Berglund; David A Fenstermacher
Journal:  BMC Bioinformatics       Date:  2013-05-07       Impact factor: 3.169

3.  A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung Adenocarcinoma.

Authors:  Paul A Stewart; Katja Parapatics; Eric A Welsh; André C Müller; Haoyun Cao; Bin Fang; John M Koomen; Steven A Eschrich; Keiryn L Bennett; Eric B Haura
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.